Both AHSG and ECM1 have been shown to have significantly higher expression in serum-derived exosomes of NSCLC patients than in those of healthy individuals and were proposed to be diagnostic biomarkers for NSCLC [131]. The gene discussed is ECM1; the disease is non-small cell lung carcinoma.